Bethany Grant News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bethany Grant. Real-time updates on events, politics, business and more.

Ganymede Bio and Kytopen Partner to Bring Cloud-Native, Structured Data to Gene-Modified Cell Therapy Instruments

September 19, 2023

/PRNewswire/ -- Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, and Kytopen, a leader in the...

United States Kytopen Flowfect Nathan Clark Flowfect Discover Bethany Grant Chief Technology Officer

Source: prnewswire.com

BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing

June 6, 2023

/PRNewswire/ -- BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy announced today that it has...

United Kingdom South Korea Pauloa Garcia Prnewswire Biocentriq Kytopen Flowfect Haro Hartounian

Source: prnewswire.com

BioCentriq Releases Results of Study Designed to Test Transfection of T-cells Using Kytopen's Flowfect® Technology

January 26, 2023

/PRNewswire/ -- BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)—announced today that...

South Korea Alex Klarer Kytopen Flowfect Biocentriq Inc New Jersey Based Large Scale Transfection

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Bethany Grant News Today

Ganymede Bio and Kytopen Partner to Bring Cloud-Native, Structured Data to Gene-Modified Cell Therapy Instruments

BioCentriq&#xAE; and Kytopen&#xAE; Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing

BioCentriq Releases Results of Study Designed to Test Transfection of T-cells Using Kytopen's Flowfect&#xAE; Technology

Explore More Categories

BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing

BioCentriq Releases Results of Study Designed to Test Transfection of T-cells Using Kytopen's Flowfect® Technology